According to Ironwood Pharmaceuticals 's latest financial reports the company's total liabilities are C$0.89 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | C$1.08 B | 78.28% |
2022-12-31 | C$0.60 B | -8.42% |
2021-12-31 | C$0.66 B | 4.87% |
2020-12-31 | C$0.63 B | -2.25% |
2019-12-31 | C$0.64 B | -10% |
2018-12-31 | C$0.71 B | -3.91% |
2017-12-31 | C$0.74 B | -13.32% |
2016-12-31 | C$0.86 B | 18.9% |
2015-12-31 | C$0.72 B | 160.15% |
2014-12-31 | C$0.27 B | 9.03% |
2013-12-31 | C$0.25 B | 200.17% |
2012-12-31 | C$85.37 M | -15.33% |
2011-12-31 | C$0.10 B | -28.87% |
2010-12-31 | C$0.14 B | -70.76% |
2009-12-31 | C$0.48 B | 8.13% |
2008-12-31 | C$0.44 B | 43.02% |
2007-12-31 | C$0.31 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() Nektar Therapeutics
NKTR | C$0.32 B | -63.33% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | C$88.58 B | 9,748.08% | ๐ฌ๐ง UK |